What changed: Cardiac amyloidosis (transthyretin, ATTR-CM)
Every dated change on the records linked to Cardiac amyloidosis (transthyretin, ATTR-CM), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Approval2This record1
September 2026 · 1
1976 · 2
- 1976ApprovalTechnetium Tc-99m pyrophosphateTechnetium Tc-99m pyrophosphate approved in US
Skeletal imaging to demonstrate areas of altered osteogenesis
- 1976ApprovalTechnetium Tc-99m pyrophosphateTechnetium Tc-99m pyrophosphate approved in US
Cardiac imaging as an adjunct in the diagnosis of acute myocardial infarction